Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
Intermediate of alvimopan and synthesis method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A kind of technology of avimopanate and intermediate, applied in the field of medicinal chemistry synthesis
Active Publication Date: 2011-07-20
BRIGHTGENE BIO MEDICAL TECH (SUZHOU) CO LTD
View PDF5 Cites 17 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although this route improves the utilization rate of piperidine raw materials and reduces the production cost to a certain extent, the chiral center in this route still has to rely on resolution to obtain a single configuration, and the yield is low, which limits this route. Application of the method in actual production
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 7
[0075] The preparation of embodiment 7 avimopandoxate hydrochloride
[0076]
[0077] Take (+)-(3R, 4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidine (synthesized with reference to the method disclosed in US5250542) 20.5g, VIII 1 Compound 37.7g was added to 200ml of acetonitrile, and then 10.1g of triethylamine was added, and heated to reflux for 10 hours. After cooling, concentrate to remove acetonitrile, add 200ml ethyl acetate, wash twice with 100ml water, dry the ethyl acetate layer with anhydrous sodium sulfate, filter to remove the desiccant, add 4M HCl ethyl acetate dropwise, adjust pH=3, stir and crystallize , filtered to get IX 1 The hydrochloride of avimopandoxate was 42.8g, the yield was 87.5%, and the HPLC purity was 99.6%.
[0081] Get according to the IX that the method shown in embodiment 7 makes 1 Add 48.9g of avimopandoxate hydrochloride, add 1L of ethanol, then add 250ml of water, adjust the pH to 13 with 50% sodium hydroxide, react for half an hour, adjust the pH to 6 with concentrated hydrochloric acid, stir and crystallize, filter, wash with water, After drying under reduced pressure at room temperature, 39.0 g of X avimopan was obtained, with a yield of 85.1% and a purity of 99.7% by HPLC.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention mainly relates to a synthesis method of alvimopan. A preparation method of the related alvimopan comprises the following steps of: condensing phenylpropionic acid and substituted oxazolidone; undergoing reaction with chloromethyl benzyl ether under the action of a catalyst to obtain a single configuration; hydrolyzing, and recycling oxazolidone to obtain carboxylic acid; condensing with glycinate; performing deprotection and undergoing reaction with a leaving group donor; butting with (+)-(3R,4R)-4-(3-hydroxy phenyl)-3,4-dimethyl piperidine to obtain alvimopan ester; and hydrolyzing to obtain the alvimopan. The invention also relates to a novel intermediate of the alvimopan and preparation methods of the alvimopan and the novel intermediate of the alvimopan. The technical scheme of the invention has the advantages of simple process, low cost and high product purity, and is suitable for industrial production.
Description
technical field [0001] The invention belongs to the technical field of pharmaceutical chemical synthesis, and in particular relates to a new avimopan intermediate and a synthesis method thereof. Background technique [0002] The chemical name of Alvimopan is: [[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidine-1- Base] methyl] -3-phenylpropionyl] amino] acetic acid, the molecular formula is C 25 h 32 N 2 o 4 , molecular weight 424.53, has the following chemical structure: [0003] [0004] Avimopan is a highly selective peripheral mu opioid receptor antagonist jointly developed by GlaxoSmithKline (GSK) and Adolor. Opioids and opioid receptors play an important role in regulating gastrointestinal function. During surgery, especially abdominal surgery, the use of opioid analgesics can cause gastrointestinal dysfunction, manifested as anorexia, nausea, flatulence, and abdominal distension. , reduced defecation, and intestinal obstruction, the use of selective...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.